Literature DB >> 12115098

Does patient sex affect human immunodeficiency virus levels?

Monica Gandhi1, Peter Bacchetti, Paolo Miotti, Thomas C Quinn, Fulvia Veronese, Ruth M Greenblatt.   

Abstract

We undertook a critical epidemiological review of the available evidence concerning whether women have lower levels of human immunodeficiency virus (HIV) RNA than do men at similar stages of HIV infection. The 13 studies included in this analysis reported viral load measurements in HIV-infected men and women at a single point in time (cross-sectional studies) or over time (longitudinal studies). Seven of the 9 cross-sectional studies demonstrated that women had 0.13-0.35 log(10) ( approximately 2-fold) lower levels of HIV RNA than do men, despite controlling for CD4(+) cell count. Four longitudinal studies revealed that women had 0.33-0.78 log(10) (2- to 6-fold) lower levels of HIV RNA than do men, even when controlling for time since seroconversion. Adjustment for possible confounders of the relationship between sex and viral load, including age, race, mode of virus transmission, and antiretroviral therapy use, did not change this outcome. This finding is significant, because viral loads are frequently used to guide the initiation and modification of antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115098     DOI: 10.1086/341249

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  77 in total

1.  ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling.

Authors:  Sheila M Adams; Marina V Aksenova; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  Synapse       Date:  2010-11       Impact factor: 2.562

2.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

3.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

4.  Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

Authors:  Manuela García de la Hera; Inmaculada Ferreros; Julia del Amo; Patricia García de Olalla; Santiago Pérez Hoyos; Roberto Muga; Jorge del Romero; Rafael Guerrero; Ildefonso Hernández-Aguado
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

5.  Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.

Authors:  Barbara Metch; Ian Frank; Richard Novak; Edith Swann; David Metzger; Cecilia Morgan; Debbie Lucy; Debora Dunbar; Parrie Graham; Tamra Madenwald; Gina Escamilia; Beryl Koblin
Journal:  AIDS Behav       Date:  2013-02

6.  Gender-based differences in treatment and outcome among HIV patients in South India.

Authors:  N Kumarasamy; K K Venkatesh; A J Cecelia; B Devaleenol; S Saghayam; T Yepthomi; P Balakrishnan; T Flanigan; S Solomon; K H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2008-11       Impact factor: 2.681

7.  Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol.

Authors:  Elina El-Badry; Gladys Macharia; Daniel Claiborne; Kelsie Brooks; Darío A Dilernia; Paul Goepfert; William Kilembe; Susan Allen; Jill Gilmour; Eric Hunter
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

8.  Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria.

Authors:  Baba M Musa; Musa A Garbati; Ibrahim M Nashabaru; Shehu M Yusuf; Aisha M Nalado; Daiyabu A Ibrahim; Melynda N Simmons; Muktar H Aliyu
Journal:  Int Health       Date:  2016-12-09       Impact factor: 2.473

9.  Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.

Authors:  Joel Emery; Neora Pick; Edward J Mills; Curtis L Cooper
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

10.  Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.

Authors:  Beryl A Koblin; Barbara Metch; Richard M Novak; Cecilia Morgan; Debbie Lucy; Debora Dunbar; Parrie Graham; Edith Swann; Tamra Madenwald; Gina Escamilia; Ian Frank
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.